<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03781141</url>
  </required_header>
  <id_info>
    <org_study_id>18-004267</org_study_id>
    <nct_id>NCT03781141</nct_id>
  </id_info>
  <brief_title>Wound Closure Study in Carpal Tunnel and Trigger Finger Surgery</brief_title>
  <official_title>Absorbable Versus Non-Absorbable Suture in Carpal Tunnel and Trigger Finger Wound Closure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does a difference in patient satisfaction and cosmetic outcome exist between wound closure
      with absorbable or non-absorbable sutures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will involve randomizing patients to wound closure with absorbable or
      non-absorbable sutures. We will if scar formation (symptoms and aesthetics) if different
      between the two types of closures as determined by the patient and observer scar assessment
      scale version 2.0 (POSAS) and the patient-rated wrist/hand evaluation (PRWHE), between
      absorbable and non-absorbable suture for wound closure of open carpal tunnel release and
      trigger finger pulley release.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Blinded assessment for wound healing</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Scar formation with the Patient and Observer Scare Assessment Scale</measure>
    <time_frame>1 year</time_frame>
    <description>Blinded scar assessment utilizing the patient and observer scar assessment scale version 2.0 (POSAS).
The POSAS is scored from the perspective of the patient and a blinded observer independently. Scores range from 1 to 10 with 1 indicating normal skin and 10 indicating the worst scar imaginable. The 1 to 10 scoring is performed in 6 domains of various scar characteristics to obtain a total score ranging from 10 to 60. Additionally, there is an overall scar appearance score that ranges from 1 to 10 with 1 indicating normal skin and 10 indicating the worst scar imaginable.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <condition>Trigger Finger</condition>
  <arm_group>
    <arm_group_label>Absorbable suture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wound closure with absorbable suture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-absorbable suture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wound closure with non-absorbable suture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound closure</intervention_name>
    <description>Comparison of two wound closures</description>
    <arm_group_label>Absorbable suture</arm_group_label>
    <arm_group_label>Non-absorbable suture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient greater than or equal to 18 years of age.

          -  Any patient undergoing primary open carpal tunnel release or primary trigger finger
             pulley release

        Exclusion Criteria:

          -  Any patient identified outside of the proposed study time period.

          -  Any patient receiving revision surgery

          -  Patients who have had prior ipsilateral palmar or finger surgery

          -  Patients with Dupuytren's disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter C Rhee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Rhee, DO</last_name>
      <phone>507-284-3664</phone>
      <email>rhee.peter@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>December 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2018</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Peter C. Rhee</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigger Finger Disorder</mesh_term>
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

